Yao, Wenqing,Zhou, Jincong,Xu, Meizhong,Zhang, Fenglei,Metcalf, Brian
申请号：
HRP20160180
公开号：
HRP20160180T1
申请日:
2016.02.22
申请国别(地区):
HR
年份:
2016
代理人:
摘要：
The present invention provides a compound of Formula (I) or Formula (II): enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula (I) and (II) are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
